Cargando…
Successful simultaneous targeting of IgE and IL-5 in a severe asthmatic patient selected for lung transplantation()
We report a case of severe uncontrolled allergic and eosinophilic asthma in which omalizumab had led to a fast remission. After 18 months, mepolizumab was added to omalizumab because of increased blood eosinophils and a deterioration of asthma control. Asthma was then under control for the next 18 m...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356159/ https://www.ncbi.nlm.nih.gov/pubmed/35983568 http://dx.doi.org/10.1016/j.waojou.2022.100669 |